| Title: | Proteome-wide Mendelian randomization identified potential drug targets for migraine |
| Journal: | The Journal of Headache and Pain |
| Published: | 11 Sep 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39261750/ |
| DOI: | https://doi.org/10.1186/s10194-024-01853-9 |
Publication 13505
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundMigraine is a highly prevalent and complex neurovascular disease. However, the currently available therapeutic drugs often fall to adequately meet clinical needs due to limited effectiveness and numerous undesirable side effects. This study aims to identify putative novel targets for migraine treatment through proteome-wide Mendelian randomization (MR).MethodsWe utilized MR to estimate the causal effects of plasma proteins on migraine and its two subtypes, migraine with aura (MA) and without aura (MO). This analysis integrated plasma protein quantitative trait loci (pQTL) data with genome-wide association studies (GWAS) findings for these migraine phenotypes. Moreover, we conducted a phenome-wide MR assessment, enrichment analysis, protein-protein interaction networks construction, and mediation MR analysis to further validate the pharmaceutical potential of the identified protein targets.ResultsWe identified 35 protein targets for migraine and its subtypes (p < 8.04 × 10-6), with prioritized targets showing minimal side effects. Phenome-wide MR identified novel protein targets - FCAR, UBE2L6, LATS1, PDCD1LG2, and MMP3 - that have no major disease side effects and interacted with current acute migraine medication targets. Additionally, MMP3, PDCD1LG2, and HBQ1 interacted with current preventive migraine medication targets. The causal effects of plasma protein on migraine were partly mediated by plasma metabolites (proportion of mediation from 3.8% to 21.0%).ConclusionsA set of potential protein targets for migraine and its subtypes were identified. These proteins showed rare side effects and were responsible for biological mechanisms involved in migraine pathogenesis, indicating priority for the development of migraine treatments.</p>
10 Keywords
- Blood Proteins
- Genome-Wide Association Study
- Humans
- Mendelian Randomization Analysis
- Migraine Disorders
- Migraine with Aura
- Migraine without Aura
- Protein Interaction Maps
- Proteome
- Quantitative Trait Loci
9 Authors
- Zhonghua Xiong
- Lei Zhao
- Yanliang Mei
- Dong Qiu
- Xiaoshuang Li
- Peng Zhang
- Mantian Zhang
- Jin Cao
- Yonggang Wang
Enabling scientific discoveries that improve human health